Next Century Growth Investors’s Evolent Health EVH Stock Holding History

Next Century Growth Investors’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-534,543	Closed	-$13.6M	–	149
2017 Q2	$13.6M	Buy	534,543 +220,343	+70%	+$5.3M	1.3%	27
2017 Q1	$7.01M	Buy	+314,200	New	+$6.03M	0.59%	64
2016 Q4	–	Sell	-702,621	Closed	-$17.3M	–	157
2016 Q3	$17.3M	Buy	+702,621	New	+$16.4M	0.79%	42

Other funds holding EVH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Next Century Growth Investors's EVH Position: Q3 2017 in Review

Next Century Growth Investors sold out of Evolent Health (EVH) in Q3 2017, closing a stake of 534,543 shares — an estimated $13.6M sold.

Next Century Growth Investors first reported a position in EVH in Q3 2016 and held it in 3 quarters. The position peaked at $17.3M in Q3 2016. 166 funds tracked by Wall St. Rank hold EVH as of Q3 2017.

Next Century Growth Investors reported no remaining Evolent Health position as of Q3 2017 after selling out during the quarter.
Next Century Growth Investors sold 534,543 Evolent Health shares in Q3 2017, an estimated $13.6M.
Next Century Growth Investors first reported a position in Evolent Health in Q3 2016 and held it in 3 quarters.
Next Century Growth Investors's Evolent Health position peaked at $17.3M in Q3 2016.
166 funds tracked by Wall St. Rank held Evolent Health as of Q3 2017.

Based on Next Century Growth Investors's 13F filing for Q3 2017, filed 14 Nov 2017.